|1.||Hartung, Hans-Peter: 25 articles (08/2013 - 06/2003)|
|2.||Montalban, Xavier: 19 articles (11/2015 - 09/2002)|
|3.||Yoshida, Jun: 18 articles (01/2009 - 02/2002)|
|4.||Pozzilli, Carlo: 16 articles (11/2015 - 01/2002)|
|5.||Comabella, Manuel: 15 articles (11/2015 - 05/2002)|
|6.||Comi, Giancarlo: 15 articles (11/2015 - 05/2005)|
|7.||Bertolotto, Antonio: 14 articles (11/2015 - 01/2004)|
|8.||Oger, Joel: 14 articles (05/2015 - 08/2003)|
|9.||Mizuno, Masaaki: 14 articles (12/2008 - 02/2002)|
|10.||Río, Jordi: 13 articles (11/2015 - 10/2002)|
01/01/2010 - "Interferon beta is beneficial in multiple sclerosis; why so remains unclear. "
06/01/2003 - "Although interferon-beta (IFN-beta) has been demonstrated to be effective in the treatment of multiple sclerosis (MS) patients, the mechanism(s) underlying its beneficial effects has not been uncovered yet. "
11/27/1981 - "Ten patients with multiple sclerosis who were treated with human fibroblast interferon (IFN-B) for 6 months showed a significant reduction in their exacerbation rates compared with their rates before treatment (P < .01). "
07/01/2008 - "Several large clinical trials have demonstrated that interferon-beta (IFN-beta) therapy is effective in the treatment of multiple sclerosis (MS) patients. "
12/20/1986 - "In this randomised, double-blind, placebo-controlled, 2-year multicentre study intrathecally administered natural human fibroblast interferon (IFN-B) was effective in reducing exacerbations of multiple sclerosis (MS) in patients with exacerbating/remitting disease. "
|2.||Relapsing-Remitting Multiple Sclerosis
10/01/2001 - "Interferon-beta (IFN-beta) has been used successfully to treat patients with relapsing-remitting multiple sclerosis (MS). "
07/01/2011 - "In the absence of a better alternative, subcutaneous interferon beta is the standard first-line treatment for relapsing-remitting multiple sclerosis. "
06/01/2009 - "Treatment of relapsing-remitting multiple sclerosis with interferon beta is only partly effective, and new more effective and safe strategies are needed. "
01/01/1996 - "The results of two phase III clinical trials have recently shown that interferon-beta (IFNbeta) is effective in the treatment of relapsing-remitting multiple sclerosis (RRMS). "
05/15/2011 - "Interferon beta is widely used as first-line treatment for relapsing remitting multiple sclerosis (RRMS). "
11/01/2002 - "In patients with hepatitis C virus infection interferon-beta therapy is most effective when administered by the intravenous route. "
09/01/1989 - "The most effective treatment of chronic HBV-infection today is the therapy with alpha- or beta-interferon. "
03/01/1988 - "Recombinant murine beta interferon was protective and therapeutic for mice against Listeria monocytogenes infection in vivo. "
08/15/2003 - "A study was undertaken to evaluate the efficacy of an adenoviral construct expressing the murine interferon-beta (IFN-beta) transgene (Ad:IFN-beta) against herpes simplex virus type 1 (HSV-1) infection in a primary trigeminal ganglion (TG) cell culture. "
08/01/2002 - "A study was undertaken to evaluate the efficacy of an adenoviral vector containing the murine interferon-beta (IFN-beta) transgene (Ad:IFN-beta) against herpes simplex virus type 1 (HSV-1) infection in two transduced cell lines. "
|4.||Chronic Hepatitis C
07/01/2000 - "Several pretreatment factors have been reported to be useful in predicting patients with a high probability for a sustained response to IFN-alpha treatment, however, predictors of the efficacy of interferon-beta treatment in chronic hepatitis C have not been fully assessed. "
04/01/1998 - "However, due to the high cost of beta interferon, this high-dose schedule would probably not be cost-effective in the treatment of chronic hepatitis C."
05/01/2003 - "The intravenous administration of interferon-beta may be effective for the treatment of chronic hepatitis C, as is intramuscular interferon-beta. "
04/01/1998 - "The intramuscular use of beta interferon has been tested in the treatment of chronic hepatitis C, but it did not prove effective when the schedule was 3 million units three times a week for six months. "
01/01/2008 - "The efficacy of short-term interferon-beta therapy for chronic hepatitis C patients with low virus load."
01/01/2004 - "Our goals were to determine the mechanisms responsible for this loss of efficacy and to test the hypothesis that the combination of preoperative adenovirus encoding interferon-beta and surgical resection would be effective in treating bulky tumors. "
11/01/2008 - "We have shown that continuous systemic delivery of interferon beta (IFN-beta) remodels dysfunctional tumor vasculature, thereby improving tumor perfusion and enhancing delivery and efficacy of chemotherapeutic drugs. "
02/01/2006 - "The purpose of this study was to investigate the therapeutic potential of interferon-beta (IFN-beta) against tumors that resist its antiproliferative effects. "
07/01/2004 - "In this study, we constructed a novel adeno-associated virus (AAV) vector containing the human interferon-beta (hIFN-beta) gene under the control of hTERT promoter (AAV-hTERT-hIFN-beta) and investigated its antitumor effect against various human cancer cells in vitro. "
09/01/2002 - "In previous studies interferon-beta (IFNbeta) has been shown to suppress tumor growth. "
|1.||copolymer 1 (glatiramer acetate)
|3.||Interferon-alpha (Interferon Alfa)
|7.||DNA (Deoxyribonucleic Acid)
|2.||Drug Therapy (Chemotherapy)
|3.||Heterologous Transplantation (Xenotransplantation)